$329.75
1.06% day before yesterday
NYSE, Sep 06, 10:10 pm CET
ISIN
US0905721082
Symbol
BIO
Index
Sector

Bio-Rad Laboratories, Inc. Class B Stock price

$329.75
+2.82 0.86% 1M
-3.50 1.05% 6M
+6.86 2.12% YTD
-40.23 10.87% 1Y
-489.95 59.77% 3Y
-5.84 1.74% 5Y
+209.51 174.24% 10Y
NYSE, Closing price Fri, Sep 06 2024
-3.53 1.06%
ISIN
US0905721082
Symbol
BIO
Index
Sector

Key metrics

Market capitalization $9.19b
Enterprise Value $8.96b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.50
P/S ratio (TTM) P/S ratio 3.59
P/B ratio (TTM) P/B ratio 1.37
Revenue growth (TTM) Revenue growth -7.46%
Revenue (TTM) Revenue $2.56b
EBIT (operating result TTM) EBIT $361.44m
Free Cash Flow (TTM) Free Cash Flow $-214.82m
Cash position $1.62b
EPS (TTM) EPS $-47.04
P/E forward 31.98
P/S forward 3.57
EV/Sales forward 3.48
Short interest 5.46%
Show more

Is Bio-Rad Laboratories, Inc. Class B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Bio-Rad Laboratories, Inc. Class B Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

4x Buy
44%
5x Hold
56%

Analyst Opinions

9 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

Buy
44%
Hold
56%

Financial data from Bio-Rad Laboratories, Inc. Class B

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2,563 2,563
7% 7%
100%
- Direct Costs 1,179 1,179
7% 7%
46%
1,384 1,384
8% 8%
54%
- Selling and Administrative Expenses 613 613
6% 6%
24%
- Research and Development Expense 214 214
21% 21%
8%
557 557
4% 4%
22%
- Depreciation and Amortization 196 196
0% 0%
8%
EBIT (Operating Income) EBIT 361 361
6% 6%
14%
Net Profit -1,326 -1,326
208% 208%
-52%

In millions USD.

Don't miss a Thing! We will send you all news about Bio-Rad Laboratories, Inc. Class B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bio-Rad Laboratories, Inc. Class B Stock News

Neutral
PRNewsWire
one day ago
NEW YORK , Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance.
Neutral
Business Wire
16 days ago
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during Wells Fargo's 2024 Healthcare Conference on Wednesday, September 4...
Neutral
Business Wire
18 days ago
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Jon DiVincenzo will join the company as President and Chief Operating Officer, effective September 9, 2024, replacing Andy Last, who is retiring. Mr. DiVincenzo joins Bio-Rad from Labcorp Holdings Inc., a global pro...
More Bio-Rad Laboratories, Inc. Class B News

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Head office United States
CEO Norman Schwartz
Employees 8,030
Founded 1952
Website www.bio-rad.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today